Hernia Clinical Trial - Stepwise for the Treatment of Lateral Incisional

Status Completed

Clinical Trial Summary

The best approach for lateral incisional hernia is not known. Posterior component separation (reverse TAR) offers the possibility of using the retromuscular space for medial extension of the challenging preperitoneal plane. The main objective of the study was to describe the surgical techniques used and their outcomes in the open lateral approach for the treatment of L3-L4 European Hernia Society (EHS) classification Incisional hernias, comparing the results between reverse TAR and pure lateral retromuscular preperitoneal, and analyzing the short- and long- term complications, including patient-reported outcomes measures (PROMs). The study report followed the recommendations for reporting outcomes in abdominal wall hernias, and the new international classification of abdominal wall planes (ICAP). A multicenter retrospective observational study was conducted using a prospectively maintained database from three university hospitals in Spain specialized in complex abdominal wall reconstruction. All patients undergoing open abdominal wall repair through the previous lateral incision for L3-L4 IHs between February 2012 and January 2020 were identified. All patients were operated on by the senior surgeons responsible for the complex abdominal wall units of each participating center. Prior to conducting the study, the approval of the local ethics committee was obtained (ID:39/2019). Written informed consent was also obtained. The diagnosis of IH was based on clinical examination and imaging from a computed tomography (CT). The investigator only included patients with L3-L4 IHs. Patients with primary lateral hernias, such as Spiegel, Grynfelt and Petit hernias were excluded. We also excluded all patients in which the lateral IH was a parastomal hernia. Demographic data, patient comorbidities, different classifications of hernia complexity, Carolinas Equation for Determining Associated Risks (CeDAR) and intraoperative and postoperative data were collected All patients followed a similar preoperative optimization program, which included endocrinologic and nutritional evaluations, respiratory physiotherapy, and abstinence from smoking at least 1 month before surgery. Weight loss was extremely recommended but without any mandatory prerequisite.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05205213
Study type	Observational
Source	Henares University Hospital
Contact
Status	Completed
Phase
Start date	February 6, 2012
Completion date	December 29, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01629485` - Part vs Whole Task Mastery Training for Laparoscopic Hernia Repair	N/A
Terminated	`NCT01305486` - A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation	N/A
Completed	`NCT01205399` - A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft	N/A
Completed	`NCT01141335` - Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair	Phase 4
Completed	`NCT00905320` - Hernia Repair With or Without Sutures	N/A
Completed	`NCT00617357` - Repair of Infected or Contaminated Hernias	N/A
Completed	`NCT00535990` - Minimally Invasive Surgery (MIS) Database for the Purpose of Research
Withdrawn	`NCT00138957` - Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh	N/A
Not yet recruiting	`NCT06034652` - T-GENVIH-003 LTFU (Long Term Follow Up) Study
Completed	`NCT04119466` - Stabilizing Training in Degenerative Disc Disease	N/A
Completed	`NCT00622583` - International Hernia Mesh Registry
Completed	`NCT04137172` - Short Term Outcomes of Laparoscopic Intraperitoneal Onlay Mesh With Facial Repair(IPOM-plus) for Ventral Hernia.	N/A
Completed	`NCT01132209` - Suture Techniques to Reduce the Incidence of The inCisional Hernia	N/A
Completed	`NCT00032448` - Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?	Phase 3
Not yet recruiting	`NCT05061589` - Incidence and Risk Factors of Parastomal Hernia in Patients With Permanent Colostomy in China
Active, not recruiting	`NCT02439060` - PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)	N/A
Completed	`NCT02238964` - Reinforcement of Closure of Stoma Site	Phase 2/Phase 3
Completed	`NCT01727388` - Informativeness to Digital Rectal Examination	Phase 3
Completed	`NCT01997619` - Biological Mesh Repair of Complex Hernias in High Risk Patients	N/A
Recruiting	`NCT00544583` - Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Stepwise for the Treatment of Lateral Incisional Hernias

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms